The Period Between 2021-2031 To See The Guided Bone Regeneration Market Scaling Innovative Heights

 According to the latest research by Persistence Market Research, Guided Bone Regeneration market is anticipated to grow at 6.3% CAGR during the forecast period. The Guided Bone Regeneration demand outlook is supposed to witness steady rise in the forecast period giving the manufacturers numerous beneficial opportunities of development in the near future.

The market for dental guided bone regeneration membranes will grow in response to the rising demand for dental implants and increasing incidence of oral health issues such as oral cancer and periodontal disease. In addition, manufacturers will increase market expansion in the anticipated time by expanding product development and focusing on meeting demand for effective therapies.

Increased awareness regarding implant procedures amongst the population of developing countries like India, Japan, Australia, and more is expected to drive the demand for guided bone regeneration market in the forecast period. India is one of the major market for dental implants.

Dental implants are gaining popularity in the U.S. because they are more functional than alternative treatment methods. Other factors like higher disposable incomes, combined with longer life expectancies, have increased the number of people seeking dental treatment. Furthermore, the introduction of new materials and technology, as well as the inclusion of dental implants in health insurance policies, are moving the guided bone regeneration industry forward.

Get Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/32985

According to a report published by the Center of Disease Control and Prevention, it was estimated that approximately 47.2% of the population above 30 years of age and 70.1% of the geriatric population in the U.S. suffers from some form of periodontal disease.

Periodontal disease is one of the major reason for surgeries involving guided bone regeneration. Thus, increased incidence of periodontal disease is expected to fuel the growth of guided bone regeneration market during the forecast period.

Additive manufacturing (AM) is a process where 3D structures are produced using automation by successive deposition of materials, layer-by-layer which is directed using Computer-Aided-Design (CAD) software.

The current clinical procedures that are aimed to reconstruct the hard or soft tissue defects which result from periodontal disease, congenital or acquired pathology or sometimes even trauma-related to the maxillofacial region, use mass-produced biomaterials for all the surgical indications. But, with the advent of AM, there is a paradigm shift in the manufacturing of these biomaterials with respect to individual patient needs.

The CAD systems use specific algorithms to design customized, image-based scaffolds with shape complexity and spatial patterning guided by topology optimization to create membranes for guided tissue regeneration specialized for every patient.

The U.S. and Canada region accounted for a significant share of the guided bone regeneration market on account of the usage of new and innovative products and technologies being used for treating various periodontal diseases. Along with the aforementioned factor, increased awareness and adoption of implant procedures amongst the population in this region is another reason why the industry will experience lucrative growth in the forecast period.

For instance, Orthocell, an Australia based regenerative medicine company received US 510k clearance in January 2021, to market and supply its collagen medical device StriateTM in the U.S. catering to the dental bone and tissue regeneration market.

Get a Customized Scope to Match Your Need Ask an Expert- sales@persistencemarketresearch.com

Europe region has the second-highest share of the guided bone regeneration industry after the U.S. and Canada region. This can be accounted for by the increased consumer awareness and knowledge about the benefits and perks of regenerative procedures to treat bone defects due to periodontal disease or other diseases affecting the oral cavity.

The reabsorbale membranes are more widely used in the European region. Increased disposable income, rising adoption of implant procedures by both physicians and patients, the inclusion of dental implants in the health insurances are some other reasons which will impact the guided bone regeneration market positively in the region during the forecast period.

For instance, Osstem Implant announced a product launch in April 2021, which was an addition to their guided bone regeneration portfolio called the ‘OssMem’, which is a bone regeneration membrane that would function both as a barrier and as a bioactive compartment. This product is aimed to ensure structural integrity essential for the regenerative function of the surgical site.

The dominant players of Guided Bone Regeneration industry are,

  • Geistlich
  • Zimmer Biomet Holdings
  • Danher Corporation
  • Dentsply Sirona
  • ACE Surgical
  • OraPharma
  • Biotiss Biomaterials
  • Keystone Dental
  • Orthocell
  • OssTem
  • Yantai Zhenghai Bio-tech Co. Ltd.
  • Genoss
  • Dentegris
  • Biotech.

In September 2021, Geistlich Pharma became an exclusive distribution partner for NUsurface meniscus implant in Switzerland as a part of an exclusive partnership with Active Implants.

Access Full Report@ https://www.persistencemarketresearch.com/checkout/32985

About Us: - Persistence Market Research

Contact us:

Persistence Market Research
Address – 305 Broadway, 7th Floor New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com

Comments

Post a Comment

Popular posts from this blog

The Metabolomics Biomarker Market to Grow Beyond Linear Progression

  The Metabolomics Biomarker Market is all set to go great guns in the forecast period. Big data makes way for real-time data visualization, thereby identifying the high-risk populations. Healthcare organizations are into sharing more data. This creation and collection of bigger datasets are likely to increase precision and help organizations in spotting trends. These trends are expected to keep the entire healthcare vertical on the toes. Metabolomics Biomarkers are used for discovery of new insights, assessment method and treatment options for pathological diseases other than the traditional ideas. Metabolites are small molecules which are responsible for cellular processes and metabolism in an organism. Metabolites are used for biomarker discovery by metabolite profiling in cells, tissues or biofluids. Biomarkers acts as indicators for response in the form of a biological process of a drug, toxin or therapy. Metabolomics biomarkers are also used to evaluate the progress of the di...
Read more

The Clinical Trial Management System Market to virtually grow beyond geographies

  The Clinical Trial Management System Market is all set to be in the driver’s seat shortly. Technology adoption once looked upon as a costly endeavor, is slated to witness a drastic transformation in the form of granular applications. Technologies like DevOps and AIOps are constructively disrupting the healthcare IT sector and are expected to create wonders in this regard in the upcoming period. Persistence Market Research has recently published a  global market study on  clinical trial management systems . The market is estimated to be valued at  US$ 2 Bn  in 2021 and is expected to surge at a  CAGR of 14%  from 2021 to 2031, to reach an estimated value of  US$ 7 Bn  by the end of 2031. Clinical trial is a medical research study performed on humans to check the safety and efficacy of drugs, devices and therapeutic products before they are finally launched in the market. Globally, the CTMS market is witnessing significant growth due to i...
Read more

Customization of care to drive the Cardiovascular Information Systems Market

Image
  The Cardiovascular Information Systems Market is ascertained to make greater strides in the future. The present-day and futuristic cutting-edge technology, namely IoT, AI, and Big Data operate better in a lightning-fast and reliable internet connection. The benefits of high-speed internet would be seen in telecare in the next 2-3 years, but going forward, more authentic data streams are likely to come up with better-connected devices, thereby revolutionizing the healthcare system. As the global healthcare industry addresses a paradigm shift towards coordinate care services, medical practitioners are compelled to develop databases for structuring case studies in the future. This necessitates the need for recording essential information on prevalent disorders such as cardiovascular diseases. A latest study developed by Persistence Market Research predicts that the demand for cardiovascular information systems will keep surging in the upcoming decade. And, rising adoption of structu...
Read more